Found: 7
Select item for more details and to access through your institution.
Targeting senescent cells with NKG2D-CAR T cells.
- Published in:
- Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-01976-7
- By:
- Publication type:
- Article
Characterization of a Novel Single-Chain Bispecific Antibody for Retargeting of T Cells to Tumor Cells via the TCR Co-Receptor CD8.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0095517
- By:
- Publication type:
- Article
Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy.
- Published in:
- Scientific Reports, 2017, p. 42855, doi. 10.1038/srep42855
- By:
- Publication type:
- Article
Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5.
- Published in:
- Nature Cell Biology, 2006, v. 8, n. 5, p. 435, doi. 10.1038/ncb1395
- By:
- Publication type:
- Article
Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 9, p. 1401, doi. 10.1007/s00262-019-02376-y
- By:
- Publication type:
- Article
Redirection of CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA<sup>+</sup> prostate tumor cells.
- Published in:
- Prostate, 2014, v. 74, n. 13, p. 1347, doi. 10.1002/pros.22851
- By:
- Publication type:
- Article
Simultaneous targeting of prostate stem cell antigen and prostate-specific membrane antigen improves the killing of prostate cancer cells using a novel modular T cell-retargeting system.
- Published in:
- Prostate, 2014, v. 74, n. 13, p. 1335, doi. 10.1002/pros.22850
- By:
- Publication type:
- Article